Developing novel therapies for pain and CNS disorders utilizing the 505(b)(2) pathway.
Industry: Health Care
First Day Return: -2.9%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 10/13/2015 |
Offer Price | $9.00 |
Price Range $11.00 - $13.00 | |
Offer Shares (mm) | 5.7 |
Deal Size ($mm) | $51 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 11/19/2015 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $51 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | New York, NY, United States |
Founded | 2012 |
Employees at IPO | 9 |
Website www.axsome.com |